These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1662894)

  • 1. Comparison of organ-specific toxicity of temafloxacin in animals and humans.
    Krasula RW; Pernet AG
    Am J Med; 1991 Dec; 91(6A):38S-41S. PubMed ID: 1662894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolone toxicity: methods of assessment.
    Patterson DR
    Am J Med; 1991 Dec; 91(6A):35S-37S. PubMed ID: 1767805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of temafloxacin neurotoxicity in rodents.
    Giardina WJ
    Am J Med; 1991 Dec; 91(6A):42S-44S. PubMed ID: 1662895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    Pernet AG
    Am J Med; 1991 Dec; 91(6A):162S-165S. PubMed ID: 1662888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of fluoroquinolone antibiotics. Past, present and future.
    Ball P; Tillotson G
    Drug Saf; 1995 Dec; 13(6):343-58. PubMed ID: 8652079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G; Scorer HJ; Carnegie CM
    J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adverse events during drug development: experience with temafloxacin.
    Norrby SR; Pernet AG
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():111-9. PubMed ID: 1664824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
    Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of temafloxacin, ciprofloxacin, or placebo on cerebral blood flow, glucose, and oxygen metabolism in healthy subjects by means of positron emission tomography.
    Bednarczyk EM; Green JA; Nelson AD; Leisure GA; Little D; Adler LP; Berridge MS; Panacek EA; Miraldi FD
    Clin Pharmacol Ther; 1991 Aug; 50(2):165-71. PubMed ID: 1868678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis/cervicitis.
    Mogabgab WJ
    Am J Med; 1991 Dec; 91(6A):145S-149S. PubMed ID: 1662885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
    Davey PG
    Am J Med; 1991 Dec; 91(6A):101S-105S. PubMed ID: 1662877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of uncomplicated urinary tract infections with temafloxacin.
    Iravani A
    Am J Med; 1991 Dec; 91(6A):124S-128S. PubMed ID: 1662882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.
    Sörgel F; Mahr G; Granneman GR; Stephan U; Nickel P; Muth P
    Clin Pharmacokinet; 1992; 22 Suppl 1():65-74. PubMed ID: 1319873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1991 Dec; 91(6A):129S-133S. PubMed ID: 1662883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL; Jones RN
    J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of fluoroquinolones.
    Norrby SR; Lietman PS
    Drugs; 1993; 45 Suppl 3():59-64. PubMed ID: 7689453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-effects of quinolones: comparisons between quinolones and other antibiotics.
    Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.